{
    "eid": "2-s2.0-85127604023",
    "title": "Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [],
    "authors": [
        "Hiroko Masuda",
        "Kenichi Harano",
        "Sakiko Miura",
        "Ying Wang",
        "Yuko Hirota",
        "Oi Harada",
        "Mohit Kumar Jolly",
        "Yuki Matsunaga",
        "Bora Lim",
        "Anita L. Wood",
        "Napa Parinyanitikul",
        "Hee Jin Lee",
        "Gyungyub Gong",
        "Jason T. George",
        "Herbert Levine",
        "Jangsoon Lee",
        "Xiaoping Wang",
        "Anthony Lucci",
        "Arvind Rao",
        "Brock L. Schweitzer",
        "O. Rayne Lawrence",
        "Robert S. Seitz",
        "Stephan W. Morris",
        "David R. Hout",
        "Seigo Nakamura",
        "Savitri Krishnamurthy",
        "Naoto T. Ueno"
    ],
    "citedby-count": 7,
    "ref-count": 38,
    "ref-list": [
        "Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry",
        "Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies",
        "Refinement of triple-negative breast cancer molecular subtypes: Implications for neoadjuvant chemotherapy selection",
        "Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients",
        "Triple-negative breast cancer: Clinical features and patterns of recurrence",
        "Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer",
        "Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes",
        "Adjuvant capecitabine for breast cancer",
        "Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric",
        "Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy",
        "Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype",
        "Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes",
        "Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype",
        "Directed therapy of subtypes of triple-negative breast cancer",
        "Activating ESR1 mutations in hormone-resistant metastatic breast cancer",
        "Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer",
        "Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer",
        "Trastuzumab emtansine for residual invasive HER2-positive breast cancer",
        "Molecular portraits of human breast tumours",
        "Intra-tumour heterogeneity: A looking glass for cancer?",
        "Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients",
        "Breast cancer intra-tumor heterogeneity",
        "Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes",
        "Molecular characterization of basal-like and non-basal-like triple-negative breast cancer",
        "Implications of the hybrid epithelial/mesenchymal phenotype in metastasis",
        "Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome",
        "An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to ecadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)",
        "Hybrid epithelial/mesenchymal phenotype(s): The \u201cfittest\u201d for metastasis?",
        "Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment",
        "Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer",
        "The role of ATF-2 in oncogenesis",
        "Epithelial-mesenchymal transition: NF-kappaB takes center stage",
        "Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review)",
        "TGF-beta-induced epithelial-mesenchymal transition: A link between cancer and inflammation",
        "TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops",
        "FGF-2-mediated signal transduction during endothelial mesenchymal transformation in corneal endothelial cells",
        "Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis",
        "Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2"
    ],
    "affiliation": [
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60024973",
            "affilname": "Showa University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024973",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "College Station",
            "@id": "60020547",
            "affilname": "Texas A&amp;M University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020547",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60028628",
            "affilname": "Northeastern University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028628",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bengaluru",
            "@id": "60014097",
            "affilname": "Indian Institute of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014097",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Kashiwa",
            "@id": "60010925",
            "affilname": "National Cancer Center Hospital East",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60005286",
            "affilname": "Rice University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005286",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nashville",
            "@id": "125860399",
            "affilname": "Oncocyte Corporation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125860399",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chiba",
            "@id": "100469550",
            "affilname": "Kameda General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100469550",
            "affiliation-country": "Japan"
        }
    ],
    "funding": [
        "State of Texas Rare and Aggressive Breast Cancer Research Program",
        "National Institutes of Health",
        "Breast Cancer Research Foundation",
        "University of Texas MD Anderson Cancer Center"
    ]
}